U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06927700) titled 'Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes' on April 07.
Brief Summary: This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food & Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multi...